(Q33914371)

30 July 2017

1 reference

title

Montelukast: a review of its therapeutic potential in persistent asthma (English)

1 reference

30 July 2017

0 references

Jarvis B

1

1 reference

30 July 2017

Markham A

series ordinal

2

1 reference

30 July 2017

publication date

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

59

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

891-928

1 reference

ABC of allergies. Pathogenic mechanisms: a rational basis for treatment

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Antileukotrienes in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Inflammation, inflammatory mediators, and mediator antagonists in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Induced Sputum Eicosanoid Concentrations in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Leukotrienes and airway responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Role of cysteinyl-leukotrienes and histamine in mediating intrinsic tone in isolated human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Difficult asthma or Churg-Strauss syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Prevalence of asthma symptoms, diagnosis, and treatment in 12-14 year old children across Great Britain (international study of asthma and allergies in childhood, ISAAC UK)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Prescribing and hospital admissions for asthma in east London

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Asthma guidelines: an assessment of physician understanding and practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Fortnightly review: modern drug treatment of chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Effect of asthma and its treatment on growth: four year follow up of cohort of children from general practices in Tayside, Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Leukotrienes as Mediators of Airway Obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059040-00015

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

21 January 2018

1 reference

12 December 2020

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

1 reference

12 December 2020

Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist

1 reference

12 December 2020

Life-threatening events after theophylline overdose: a 10-year prospective analysis

1 reference

12 December 2020

Theophylline. A review of its potential steroid sparing effects in asthma

1 reference

12 December 2020

Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

1 reference

12 December 2020

Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma

1 reference

12 December 2020

Leukotriene modifiers: new drugs, old and new reactions

1 reference

12 December 2020

Photoaffinity labeling of the leukotriene D4 receptor in guinea pig lung.

1 reference

12 December 2020

Childhood asthma and allergic rhinitis: the role of leukotrienes

1 reference

12 December 2020

1 reference

12 December 2020

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

1 reference

12 December 2020

Cardiac Tamponade and Peripheral Eosinophilia in a Patient Receiving Cromolyn Sodium

1 reference

12 December 2020

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

1 reference

12 December 2020

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

12 December 2020

Urinary mediators and asthma

1 reference

12 December 2020

A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma

1 reference

12 December 2020

Compliance in clinical trials of two nonbronchodilator, antiasthma medications

1 reference

12 December 2020

Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood

1 reference

12 December 2020

The emerging role of leukotriene antagonists in asthma therapy

1 reference

12 December 2020

Osteoporosis in the corticosteroid-treated patient with asthma.

1 reference

12 December 2020

Pulmonary eosinophilia associated with montelukast

1 reference

12 December 2020

Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma

1 reference

12 December 2020

Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists

1 reference

12 December 2020

Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma

1 reference

12 December 2020

Comparison of patients' compliance with prescribed oral and inhaled asthma medications

1 reference

12 December 2020

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

12 December 2020

What are minimal important changes for asthma measures in a clinical trial?

1 reference

12 December 2020

Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: A preliminary study

1 reference

12 December 2020

Inflammatory mediators of asthma: an update

1 reference

12 December 2020

Newer asthma therapies

1 reference

12 December 2020

Leukotriene receptor antagonist treatment of asthma: are we there yet?

1 reference

12 December 2020

Pulmonary infiltrates with eosinophilia in an asthmatic patient treated with disodium cromoglycate

1 reference

12 December 2020

Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration

1 reference

12 December 2020

Peptide leukotriene involvement in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig.

1 reference

12 December 2020

Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers

1 reference

12 December 2020

An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses

1 reference

12 December 2020

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

1 reference

12 December 2020

Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice.

1 reference

12 December 2020

Comparison of urinary leukotriene E4 and 16-carboxytetranordihydro leukotriene E4 excretion in allergic asthmatics after inhaled antigen

1 reference

12 December 2020

Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis

1 reference

12 December 2020

The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma

1 reference

12 December 2020

The role and contribution of leukotrienes in asthma

1 reference

12 December 2020

New Treatments for Exercise-Induced Asthma

1 reference

12 December 2020

Total Eosinophil Counts in the Management of Bronchial Asthma

1 reference

12 December 2020

A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair

1 reference

12 December 2020

Leukotriene-receptor antagonists

1 reference

12 December 2020

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

12 December 2020

Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies

1 reference

12 December 2020

Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

1 reference

12 December 2020

Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects

1 reference

12 December 2020

Leukotriene modifiers as novel therapeutics in asthma

1 reference

12 December 2020

The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children

1 reference

12 December 2020

Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma

1 reference

12 December 2020

Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonists

1 reference

12 December 2020

Eotaxin and impaired lung function in asthma

1 reference

12 December 2020

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

1 reference

12 December 2020

Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

1 reference

12 December 2020

Measuring quality of life in children with asthma.

1 reference

12 December 2020

Inhaled steroids in children: risks versus rewards

1 reference

12 December 2020

Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma

1 reference

12 December 2020

Inflammation, leukotrienes and the pathogenesis of the late asthmatic response.

1 reference

12 December 2020

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group

1 reference

12 December 2020

Treatment of aspirin-intolerant asthma with antileukotrienes

1 reference

12 December 2020

Bronchial asthma: still an inadequately assessed and improperly treated disease

1 reference

12 December 2020

Actual use of inhaled corticosteroids and risk of hospitalisation: a case-control study

1 reference

12 December 2020

Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects

1 reference

12 December 2020

Characterization of the human cysteinyl leukotriene CysLT1 receptor

1 reference

12 December 2020

Are new asthma therapies needed?

1 reference

12 December 2020

Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses

1 reference

12 December 2020

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

1 reference

12 December 2020

Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching

1 reference

12 December 2020

Theophylline in asthma

1 reference

12 December 2020

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

1 reference

12 December 2020

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

12 December 2020

Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast

1 reference

12 December 2020

Preventive pharmacologic therapy among asthmatics: five years after publication of guidelines

1 reference

12 December 2020

Short stature never killed anybody

1 reference

12 December 2020

Exercise-induced bronchospasm in children: effects of asthma severity

1 reference

12 December 2020

Leukotriene D4 activates mitogen-activated protein kinase through a protein kinase Calpha-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells

1 reference

12 December 2020

Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects

1 reference

12 December 2020

Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids

1 reference

12 December 2020

Churg-Strauss syndrome during pregnancy after steroid withdrawal

1 reference

12 December 2020

Childhood asthma and growth--a review of the literature

1 reference

12 December 2020

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

12 December 2020

In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors

1 reference

12 December 2020

Inherent tone of human bronchus: role of eicosanoids and the epithelium

1 reference

12 December 2020

Measurements of leukotrienes in the urine: strategies and applications

1 reference

12 December 2020

Can asthma be studied in the urine?

1 reference

12 December 2020

Should Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?

1 reference

12 December 2020

Comparison of guidelines and self-management plans in asthma

1 reference

12 December 2020

Churg-Strauss syndrome and antiasthma therapy

1 reference

12 December 2020

Liver Disease and Vasculitis in a Patient Taking Cromolyn

1 reference

12 December 2020

1 reference

12 December 2020

Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group

1 reference

12 December 2020

Churg-Strauss syndrome associated with zafirlukast

1 reference

12 December 2020

The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma

1 reference

12 December 2020

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

1 reference

12 December 2020

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

12 December 2020

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

1 reference

12 December 2020

Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats

1 reference

12 December 2020

Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways

1 reference

12 December 2020

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

12 December 2020

Steroids and Churg-Strauss syndrome

1 reference

12 December 2020

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

1 reference

12 December 2020

Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun.

1 reference

12 December 2020

The discovery of the leukotrienes

1 reference

12 December 2020

Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans

1 reference

12 December 2020

Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma

1 reference

12 December 2020

Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells

1 reference

12 December 2020

Use of inhaled corticosteroids and the risk of cataracts.

1 reference

12 December 2020

Effect of multiple doses of montelukast, a CysLT1 receptor antagonist, on digoxin pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma

1 reference

12 December 2020

Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.

1 reference

12 December 2020

Aspirin-induced asthma: advances in pathogenesis and management

1 reference

12 December 2020

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

1 reference

12 December 2020

Churg-Strauss syndome

1 reference

12 December 2020

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

1 reference

12 December 2020

Intracellular compartmentalization of leukotriene biosynthesis

1 reference

12 December 2020

The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma

1 reference

12 December 2020

1 reference

12 December 2020

Effect of montelukast on single-dose theophylline pharmacokinetics

1 reference

12 December 2020

Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile

1 reference

12 December 2020

Genetic mechanisms in aspirin-induced asthma

1 reference

12 December 2020

Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group

1 reference

12 December 2020

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

1 reference

12 December 2020

A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group

1 reference

12 December 2020

The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness

1 reference

12 December 2020

Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma

1 reference

12 December 2020

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

1 reference

12 December 2020

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

1 reference

12 December 2020

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

12 December 2020

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

1 reference

12 December 2020

Antileukotriene therapy. Future directions

1 reference

12 December 2020

Antileukotriene drugs in the management of asthma

1 reference

12 December 2020

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

12 December 2020

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

12 December 2020

Early and late asthmatic reaction after allergen challenge

1 reference

12 December 2020

Leukotriene receptor antagonists: useful in acute asthma?

1 reference

12 December 2020

Effects of antileukotrienes in the treatment of asthma

1 reference

12 December 2020

Mechanism of aspirin-induced asthma

1 reference

12 December 2020

Genetic and environmental interaction in allergy and asthma

1 reference

12 December 2020

Duration of growth suppressive effects of regular inhaled corticosteroids

1 reference

12 December 2020

Inhaled corticosteroid therapy in children: an assessment of the potential for side effects

1 reference

12 December 2020

Measuring quality of life in asthma

1 reference

12 December 2020

Effect of long-term salmeterol treatment on exercise-induced asthma

1 reference

12 December 2020

Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group

1 reference

12 December 2020

Measurement characteristics of two asthma symptom diary scales for use in clinical trials

1 reference

12 December 2020

Step 3 of the asthma guidelines

1 reference

12 December 2020

Formes Frustes of Churg-Strauss Syndrome

1 reference

12 December 2020

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

1 reference

12 December 2020

Undertreatment in a nonselected population of adult patients with asthma

1 reference

12 December 2020

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist

1 reference

12 December 2020

Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience

1 reference

12 December 2020

The dull-edged sword of inhaled corticosteroids

1 reference

12 December 2020

Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No

1 reference

12 December 2020

Leukotriene modifiers: what is their position in asthma therapy?

1 reference

12 December 2020

Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994.

1 reference

12 December 2020

In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans

1 reference

12 December 2020

Pharmacological characterization of leukotriene receptors

1 reference

12 December 2020

Validation of an asthma symptom diary for interventional studies

1 reference

12 December 2020

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

1 reference

12 December 2020

Exercise-induced asthma

1 reference

12 December 2020

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

12 December 2020

Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor

1 reference

12 December 2020

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

12 December 2020

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

1 reference

12 December 2020

Zafirlukast and Churg-Strauss syndrome

1 reference

12 December 2020

Pulmonary allergic granulomatosis: a possible drug reaction in a patient receiving cromolyn sodium

1 reference

12 December 2020

Leukotriene bronchoconstriction induced by allergen and exercise

1 reference

12 December 2020

Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group.

1 reference

12 December 2020

Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness

1 reference

12 December 2020

Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions

1 reference

12 December 2020

The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.

1 reference

12 December 2020

10.2165/00003495-200059040-00015

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1003115732

0 references

1 reference